Initiation of the FALCON-HD trial follows promising Phase 1 results demonstrating up to 72% reduction in HTT mRNA in healthy volunteers The SKY-0515 Phase 1 trial in patients with Huntington's disease ...

For TransCon CNP treatment-naïve children, mean annualized growth velocity (AGV) was 9.14 cm/year, representing an increase from baseline at Week 26 of 4.23 cm/year, with an improvement in mean ACH ...

The partnership between US Steel Corp and Nippon Steel Corp has reached a new phase, with an agreement on US national ...

Type C FDA consultation for phase 2 trial design has completed ... About Merry Life Biomedical Company Merry Life Biomedical is a Taiwan-based biotechnology company focused on developing ...

Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer's disease (AD). TML-6 combines ...

Google teams up with CIP on its first offshore wind PPA in APAC, backing Taiwan’s clean energy push with the 495MW Fengmiao I ...

Entering Southern Taiwan Science Park in Tainan on June 2, a long row of towering 50 meter transmission towers came into view ...

A compelling in-depth interview featured prominently in the 5th issue of The Channel Magazine () in 2025. This issue's ...

The global Patient Temperature Monitoring Market, valued at US$2.31 billion in 2024 stood at US$2.44 billion in 2025 and is projected to advance ...